# Europe-Japan Diagnostic Study for EGFR Testing

> **NCT01785888** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1311 (actual)

## Conditions studied

- EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01785888
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 1311 (ACTUAL)
- **Last updated:** 2016-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01785888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01785888, "Europe-Japan Diagnostic Study for EGFR Testing". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01785888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*